Advisor, R&D Portfolio Strategy & Management
Elanco
Summary
As Advisor, R&D Portfolio Management, you will serve as a key catalyst of the transformation journey within Elanco's Global R&D organization, playing a pivotal role in shaping Elanco's pipeline and portfolio decisions. In this dual-function role, you will modernize how Elanco manages its R&D portfolio by enhancing systems and processes—transitioning static reporting toward live, insight-guided evaluations—while partnering across the innovation community to bridge project execution with executive governance.
Job description
Your Role: Advisor, R&D Portfolio Management
As Advisor, R&D Portfolio Management, you will serve as a key catalyst of the transformation journey within Elanco's Global R&D organization, playing a pivotal role in shaping Elanco's pipeline and portfolio decisions. In this dual-function role, you will modernize how Elanco manages its R&D portfolio by enhancing systems and processes—transitioning static reporting toward live, insight-guided evaluations—while partnering across the innovation community to bridge project execution with executive governance.
Your Responsibilities
- Portfolio Management Transformation (50%): Continuously identify opportunities to enhance portfolio management processes, tools, and evaluation capabilities; champion the journey toward a single source of truth within the PPM ecosystem; guide the design and implementation of PPM data improvements in partnership with R&D and IT; and support the rollout of a PPM Intelligence solution that connects foundational data with real-time proactive insights and AI capabilities.
- Strategic Liaison (20%): Serve as an embedded strategic partner with the SPMO and Strategic Portfolio Leads, translating portfolio-level strategic intent into actionable project priorities while ensuring project milestone shifts, resource constraints, and risk changes are rapidly reflected in valuation and prioritization models to bridge project execution with executive governance.
- Portfolio Strategy (10%): Synthesize diverse inputs from Corporate Strategy, Innovation Strategy, and R&D into a holistic view of portfolio opportunities; ideate, develop, and implement evaluation frameworks to assess R&D pipelines and recommend optimal resource allocations aligned with corporate strategic goals.
- Prioritization & Resource Allocation Support (<10%): Perform portfolio-wide prioritization and trade-off assessments to enable dynamic resource allocation across the R&D pipeline, delivering clear recommendations to senior leadership to optimize the portfolio mix against clinical, commercial, and market shifts.
- Performance Monitoring, Governance & Cross-Functional Collaboration (<10%): Establish and maintain R&D portfolio health KPIs and executive dashboards; synthesize decision-ready insights for the R&D Portfolio Governance Committee (PGC); and translate complex quantitative findings into compelling strategic recommendations while fostering seamless cross-functional alignment across R&D project teams, Finance, Commercial, and Corporate Strategy.
What You Need to Succeed (minimum qualifications)
- Education: Bachelor's degree in Finance, Economics, Business Administration, Life Sciences, or a related field (or equivalent level of experience).
- Required Experience: Minimum of 8–10+ years of progressive experience in R&D Project Management within the pharmaceutical or animal health industry.
- Demonstrated experience in R&D Operations Portfolio Management or Strategic Planning within the life sciences sector.
- Demonstrated experience guiding process improvement, capability-building, or transformation initiatives.
- Top Skills: Strong financial acumen with proven expertise in large datasets, quantitative modeling, and business case formation, paired with strong communication skills and proficiency with portfolio management and BI tools (e.g., Planisware, Tableau, Power BI, Advanced Excel).
What will give you a competitive edge (preferred qualifications)
- Master's degree or MBA.
- Experience managing global R&D portfolios with strong familiarity in drug development processes and regulatory landscapes.
- Experience with enterprise PPM platforms (e.g., Fluid, MS Project Online, EPPM) and emerging AI/advanced evaluation tools applied to portfolio decision-making.
- Proven track record in change management, stakeholder partnership, and driving broad organizational adoption of new processes and systems.
Additional Information
Travel: 10% (or as required for business needs). Location: Global Elanco Headquarters - Indianapolis, IN - Hybrid Work Environment.
Requirements
- Bachelor's degree in Finance, Economics, Business Administration, Life Sciences, or a related field (or equivalent level of experience)
- Minimum of 8–10+ years of progressive experience in R&D Project Management within the pharmaceutical or animal health industry
- Demonstrated experience in R&D Operations Portfolio Management or Strategic Planning within the life sciences sector
- Demonstrated experience guiding process improvement, capability-building, or transformation initiatives
- Strong financial acumen with proven expertise in large datasets, quantitative modeling, and business case formation
- Strong communication skills
- Proficiency with portfolio management and BI tools (e.g., Planisware, Tableau, Power BI, Advanced Excel)
Benefits
- Relocation packages
- Two weeklong shutdowns
- Parental leave
- Employee resource groups
- Annual bonus
- Flexible work arrangements
- 401(k) Matching
Company overview
Elanco Animal Health Incorporated is a global leader in the animal health pharmaceutical industry, dedicated to improving the health and well-being of both pets and farm animals worldwide. Founded in 1954 as a division of Eli Lilly and Company, Elanco became an independent public company in 2018 and has since grown to become the world's second-largest independent animal health company. With approximately 9,000 employees globally, the company operates with a clear purpose: 'making life better for animals, makes life better.' Elanco develops innovative medicines, vaccines, and health solutions that empower veterinarians, farmers, and pet owners to advance animal care. The company maintains a balanced portfolio between pet health and farm animal products, offering over 200 brands that address critical health challenges ranging from companion animal diseases to livestock productivity. Headquartered in Indianapolis, Indiana, Elanco is publicly traded on the New York Stock Exchange (NYSE: ELAN) and continues to drive innovation in animal health through strategic acquisitions and dedicated research and development efforts.